GO:0042822 pyridoxal 5'-phosphate metabolic process: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042822 describes the chemical reactions and pathways involving pyridoxal 5'-phosphate (PLP), the active form of vitamin B6.
• PLP is an electrophilic catalyst that forms Schiff-base intermediates with amino acid substrates, enabling transamination, decarboxylation, racemization, and other reactions.
• PLP-dependent enzymes are phosphorylated, adding a regulatory layer that is still poorly understood.
• Beyond classical metabolism, PLP-binding proteins can interact with RNA, expanding the functional repertoire of this cofactor.
• PLP metabolism is linked to hypertension, with PLP acting as a P2X3 receptor antagonist in the carotid body and as a cost-effective treatment candidate [2,4].
• PLP-dependent enzymes are involved in natural product biosynthesis, including nucleoside antibiotics and cycloleucine synthases [6,8].
Description
Pyridoxal 5'-phosphate (PLP) is the biologically active form of vitamin B6 and serves as an essential cofactor for numerous enzymatic reactions across all domains of life. The Gene Ontology term GO:0042822, pyridoxal 5'-phosphate metabolic process, encompasses the chemical reactions and pathways involving PLP, including its biosynthesis, interconversion, and utilization in catalytic cycles. PLP-dependent enzymes catalyze a wide range of transformations, such as transamination, decarboxylation, racemization, and various carbon-carbon bond-forming reactions, making PLP metabolism central to amino acid homeostasis, neurotransmitter synthesis, and secondary metabolism. Recent studies have expanded the known roles of PLP beyond classical cofactor functions; for example, a ubiquitous PLP-binding protein has been shown to also bind RNA, suggesting additional regulatory roles. Moreover, PLP metabolism is implicated in human disease, including hypertension, where PLP antagonizes carotid body P2X3 receptors and may serve as a cost-effective treatment [2,4]. Understanding the molecular mechanisms, regulation, and disease relevance of PLP metabolism is therefore critical for both basic and translational research.
pyridoxal 5'-phosphate metabolic process At A Glance
| GO ID | GO:0042822 |
|---|---|
| GO term | pyridoxal 5'-phosphate metabolic process |
| Ontology | biological_process |
| Synonym | active vitamin B6 metabolic process; active vitamin B6 metabolism; pyridoxal phosphate metabolism |
| Major function | Chemical reactions and pathways involving pyridoxal 5'-phosphate (PLP), the active form of vitamin B6, including its role as an electrophilic catalyst in enzymatic reactions. |
| Key cofactor | Pyridoxal 5'-phosphate (PLP) itself acts as a cofactor for many enzymes. |
| Associated enzymes | PLP-dependent enzymes such as transaminases, decarboxylases, racemases, and others. |
| Regulation | Phosphorylation of PLP-dependent enzymes is an emerging regulatory mechanism. |
| Disease relevance | Hypertension, where PLP antagonizes P2X3 receptors in the carotid body. |
What Is GO:0042822?
According to the Gene Ontology, GO:0042822 pyridoxal 5'-phosphate metabolic process is defined as the chemical reactions and pathways involving pyridoxal phosphate, which is pyridoxal phosphorylated at the hydroxymethyl group of C-5 and represents the active form of vitamin B6. This process includes the biosynthesis, interconversion, and utilization of PLP as a cofactor in enzymatic reactions.
Why Is pyridoxal 5'-phosphate metabolic process Important in Cell Biology?
PLP metabolism is fundamental to cellular biochemistry because PLP is an essential cofactor for numerous enzymes involved in amino acid metabolism, neurotransmitter biosynthesis, and various biosynthetic pathways. Dysregulation of PLP-dependent processes is associated with human diseases, including hypertension, where PLP acts as a P2X3 receptor antagonist in the carotid body and has been proposed as a cost-effective treatment [2,4]. Furthermore, PLP-dependent enzymes are targets for antibiotic and drug development, as they participate in the biosynthesis of nucleoside antibiotics and other natural products [6,8]. The recent discovery that a PLP-binding protein can also bind RNA highlights additional layers of regulation and potential therapeutic targets.
• PLP is the active form of vitamin B6 and is required for amino acid metabolism, neurotransmitter synthesis, and many other pathways.
• PLP-dependent enzymes catalyze diverse reactions including transamination, decarboxylation, and carbon-carbon bond formation.
• Phosphorylation of PLP-dependent enzymes represents a regulatory mechanism that is not fully understood.
• PLP metabolism is linked to hypertension; PLP antagonizes carotid body P2X3 receptors and may be a cost-effective treatment [2,4].
• PLP-dependent enzymes are involved in the biosynthesis of nucleoside antibiotics and other natural products.
• Cycloleucine synthases are PLP-dependent enzymes with potential roles in natural product biosynthesis.
• PLP-binding proteins can interact with RNA, suggesting moonlighting functions beyond cofactor roles.
• PLP is an electrophilic catalyst that forms Schiff bases with substrates, enabling a wide range of chemical transformations.
• Understanding PLP metabolism can inform drug design targeting PLP-dependent enzymes.
• PLP metabolism is a target for metabolic engineering and synthetic biology applications.
What Happens During pyridoxal 5'-phosphate metabolic process?
PLP as an Electrophilic Catalyst
In simple terms: PLP acts like a chemical magnet that pulls electrons, helping enzymes break and form bonds in amino acids.
PLP functions as an electrophilic catalyst by forming a Schiff-base linkage with the amino group of amino acid substrates, thereby stabilizing carbanionic intermediates and facilitating diverse reactions such as transamination, decarboxylation, and racemization. This covalent catalysis is central to the metabolic process and allows a single cofactor to participate in a wide array of transformations.
Phosphorylation of PLP-Dependent Enzymes
In simple terms: Many enzymes that use PLP can be turned on or off by adding a phosphate group.
Phosphorylation of PLP-dependent enzymes is an intriguing and often neglected regulatory mechanism. This post-translational modification can alter enzyme activity, stability, or localization, thereby modulating PLP-dependent metabolic pathways. The interplay between phosphorylation and PLP binding is an active area of research.
PLP-Dependent Alkyl Transfer in Antibiotic Biosynthesis
In simple terms: PLP helps enzymes build complex antibiotic molecules by moving chemical groups.
PLP-dependent enzymes catalyze alkyl transfer reactions in the biosynthesis of nucleoside antibiotics, demonstrating the versatility of PLP in natural product chemistry. These reactions expand the known repertoire of PLP-dependent transformations beyond classical amino acid metabolism.
PLP-Dependent Decarboxylative Annulation
In simple terms: PLP enzymes can create ring structures by removing carbon dioxide and joining molecules together.
Recent work has shown that PLP-dependent enzymes can catalyze decarboxylative annulation reactions, forming complex ring systems. This highlights the role of PLP in synthetic and biosynthetic pathways, with potential applications in drug discovery and biocatalysis.
RNA Binding by PLP-Binding Proteins
In simple terms: Some proteins that bind PLP can also bind RNA, suggesting they have more than one job.
A ubiquitous PLP-binding protein has been found to also bind RNA, indicating that PLP metabolism may intersect with RNA biology. This dual function could provide additional regulatory layers and suggests that PLP-binding proteins may have roles beyond enzymatic catalysis.
Key Genes Involved in GO:0042822 pyridoxal 5'-phosphate metabolic process
The following genes and proteins are key players in pyridoxal 5'-phosphate metabolic process, based on their roles in PLP-dependent catalysis, regulation, and disease associations.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PDXP | Pyridoxal phosphatase; regulates PLP levels | Phosphorylation of PLP-dependent enzymes |
| PNPO | Pyridoxamine 5'-phosphate oxidase; converts PMP to PLP | PLP biosynthesis and epilepsy |
| PDXK | Pyridoxal kinase; phosphorylates pyridoxal to PLP | PLP metabolism and cancer |
| GOT1 | Glutamic-oxaloacetic transaminase 1; PLP-dependent | Amino acid metabolism |
| GOT2 | Glutamic-oxaloacetic transaminase 2; PLP-dependent | Amino acid metabolism |
| GPT | Glutamic-pyruvic transaminase; PLP-dependent | Liver function and metabolism |
| GAD1 | Glutamate decarboxylase 1; PLP-dependent | GABA synthesis |
| GAD2 | Glutamate decarboxylase 2; PLP-dependent | GABA synthesis |
| DDC | Dopa decarboxylase; PLP-dependent | Neurotransmitter synthesis |
| SHMT1 | Serine hydroxymethyltransferase 1; PLP-dependent | One-carbon metabolism |
| SHMT2 | Serine hydroxymethyltransferase 2; PLP-dependent | One-carbon metabolism |
| CBS | Cystathionine beta-synthase; PLP-dependent | Homocysteine metabolism |
| CTH | Cystathionine gamma-lyase; PLP-dependent | Transsulfuration |
| AOC1 | Amine oxidase copper containing 1; PLP-dependent | Histamine metabolism |
| OAT | Ornithine aminotransferase; PLP-dependent | Proline metabolism |
| AGXT | Alanine-glyoxylate aminotransferase; PLP-dependent | Primary hyperoxaluria |
| P2RX3 | P2X3 receptor; antagonized by PLP | Hypertension |
How Is pyridoxal 5'-phosphate metabolic process Regulated?
PLP metabolism is regulated at multiple levels. Phosphorylation of PLP-dependent enzymes can modulate their activity, stability, or interactions, representing a post-translational regulatory layer. Additionally, PLP levels are controlled by enzymes such as pyridoxal kinase (PDXK) and pyridoxine 5'-phosphate oxidase (PNPO), which regulate the biosynthesis and interconversion of PLP. The recent finding that a PLP-binding protein can also bind RNA suggests potential regulation at the RNA level. Furthermore, PLP itself can act as a signaling molecule, as seen in its antagonism of P2X3 receptors in the carotid body, which influences blood pressure.
pyridoxal 5'-phosphate metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PNPO | Pyridoxine-dependent epilepsy | Knockout or point-mutation cell models |
| PDXK | Cancer metabolism | Overexpression and knockout models |
| P2RX3 | Hypertension | Knockout and point-mutation models |
| AGXT | Primary hyperoxaluria | Knock-in of patient mutations |
| CBS | Homocystinuria | Knockout and point-mutation models |
Hypertension and Cardiovascular Disease
PLP has been shown to antagonize P2X3 receptors in the carotid body, reducing sympathetic activity and lowering blood pressure in hypertensive models. This suggests that PLP metabolism and signaling are directly linked to cardiovascular regulation, and PLP supplementation may be a cost-effective treatment for hypertension [2,4].
Neurological Disorders
PLP is essential for the synthesis of neurotransmitters such as GABA, dopamine, and serotonin, and mutations in PLP-metabolizing enzymes like PNPO cause pyridoxine-dependent epilepsy. Dysregulation of PLP metabolism has also been implicated in other neurological conditions, although the mechanisms are still being elucidated.
Infectious Disease and Antibiotic Resistance
PLP-dependent enzymes are involved in the biosynthesis of nucleoside antibiotics, and targeting these enzymes could lead to new antimicrobial strategies. The unique chemistry of PLP-dependent alkyl transfer and decarboxylative annulation offers opportunities for drug discovery [3,6].
From pyridoxal 5'-phosphate metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PNPO affect PLP levels and neuronal function? | PNPO knockout cell line |
| Does a specific point mutation in PDXK alter PLP binding? | Point-mutation knock-in |
| Can PLP metabolism be monitored in live cells? | Tagged knock-in of PLP-binding proteins |
| Does overexpression of GAD1 increase GABA synthesis? | Overexpression cell model |
| What genes regulate PLP homeostasis? | CRISPR library screening |
| How does PLP affect RNA binding? | RNA-binding protein knockout and overexpression |
How to Study the pyridoxal 5'-phosphate metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Gene expression changes | Identifying PLP-related pathways |
| Phosphoproteomics | Phosphorylation sites | Mapping regulation of PLP enzymes |
| CRISPR screening | Gene essentiality and function | Discovering PLP metabolism regulators |
| Metabolomics | PLP and metabolite levels | Quantifying PLP in cells |
| Enzymatic assays | Catalytic activity | Characterizing PLP-dependent enzymes |
| X-ray crystallography | Protein structure | Understanding PLP binding |
| Ribo-seq | Translation efficiency | Studying PLP enzyme synthesis |
Genomic and Transcriptomic Approaches
RNA-seq and CRISPR screening can identify genes and pathways that regulate PLP metabolism. Transcriptomic profiling of PLP-dependent enzymes under different conditions reveals regulatory networks.
Proteomic and Phosphoproteomic Analysis
Phosphoproteomics can map phosphorylation sites on PLP-dependent enzymes, providing insights into their regulation. Mass spectrometry-based proteomics can quantify PLP-binding proteins and their interactions.
Metabolic and Biochemical Assays
Enzymatic assays using PLP-dependent enzymes can measure catalytic activity and substrate specificity. Metabolomics can quantify PLP and related metabolites in cells and tissues.
Structural and Biophysical Methods
X-ray crystallography and NMR can elucidate the structure of PLP-enzyme complexes. Biophysical techniques such as isothermal titration calorimetry can measure PLP binding affinity.
How CRISPR Can Be Used to Study GO:0042822 pyridoxal 5'-phosphate metabolic process
Knockout
CRISPR knockout of PLP-metabolizing genes such as PNPO or PDXK can reveal their essentiality and impact on cellular PLP levels. Knockout cell models are valuable for studying loss-of-function phenotypes and compensatory pathways.
Point Mutation
Introducing point mutations in PLP-binding sites or catalytic residues of PLP-dependent enzymes can dissect their mechanism and regulation. Point-mutation models help validate drug targets and understand disease-associated variants.
Knock-in
Knock-in of tagged PLP-binding proteins allows real-time imaging and interaction studies. Knock-in of patient mutations can model disease and test therapeutic strategies.
Overexpression
Overexpression of PLP-dependent enzymes such as GAD1 or DDC can increase flux through specific metabolic pathways. Overexpression models are useful for studying gain-of-function effects and for bioproduction.
How EDITGENE Supports pyridoxal 5'-phosphate metabolic process Research
Researchers studying pyridoxal 5'-phosphate metabolic process-related genes often need to determine whether a candidate gene is causally involved in PLP homeostasis, disease, or drug response. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for pyridoxal 5'-phosphate metabolic process research.
Frequently Asked Questions About pyridoxal 5'-phosphate metabolic process
What is pyridoxal 5'-phosphate metabolic process?
It is the set of chemical reactions and pathways involving pyridoxal 5'-phosphate (PLP), the active form of vitamin B6, as defined by GO:0042822.
What genes are involved in pyridoxal 5'-phosphate metabolic process?
Key genes include PNPO, PDXK, GOT1, GOT2, GAD1, GAD2, DDC, SHMT1, SHMT2, CBS, and others encoding PLP-dependent enzymes.
What is the role of PLP in the body?
PLP is an essential cofactor for many enzymes involved in amino acid metabolism, neurotransmitter synthesis, and other pathways.
How is PLP metabolism regulated?
PLP metabolism is regulated by phosphorylation of PLP-dependent enzymes and by the enzymes that synthesize and degrade PLP.
What diseases are associated with PLP metabolism?
Diseases include hypertension, pyridoxine-dependent epilepsy, and disorders of amino acid metabolism [2,4,7].
Can PLP be used to treat hypertension?
PLP has been shown to antagonize P2X3 receptors in the carotid body and may be a cost-effective treatment for hypertension [2,4].
What are PLP-dependent enzymes?
They are enzymes that require PLP as a cofactor to catalyze reactions such as transamination, decarboxylation, and racemization.
How can I study PLP metabolism in the lab?
Methods include CRISPR knockout, point mutation, knock-in, overexpression, metabolomics, and proteomics [5,7].
What is the connection between PLP and RNA?
A ubiquitous PLP-binding protein has been found to also bind RNA, suggesting dual functions.
What CRISPR services does EDITGENE offer for PLP research?
EDITGENE provides knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services for PLP-related genes.
Conclusion
Pyridoxal 5'-phosphate metabolic process (GO:0042822) is a fundamental biological process centered on the active form of vitamin B6, which serves as an essential cofactor for numerous enzymes. Its importance spans basic metabolism, neurotransmitter synthesis, natural product biosynthesis, and human diseases such as hypertension and epilepsy [2,4,6,7]. Recent discoveries, including RNA binding by PLP-binding proteins and phosphorylation of PLP enzymes, continue to expand our understanding of this versatile cofactor [1,5]. Researchers can leverage CRISPR-based models and multi-omics approaches to further dissect PLP metabolism and its therapeutic potential.
References
- 1. Graziani C et al.. 2024. The ubiquitous pyridoxal 5'-phosphate-binding protein is also an RNA-binding protein.. Protein Sci 33(12):e5242 PMID: 39604152
- 2. Lellig M et al.. 2024. Pyridoxal-5'-phosphate: A cost-effective treatment candidate for hypertensive patients?. J Intern Med 296(5):435-448 PMID: 39385670
- 3. Chai W et al.. 2026. Pyridoxal 5'-Phosphate-Dependent Enzymatic Decarboxylative Annulation.. J Am Chem Soc 148(9):9709-9719 PMID: 41769737
- 4. Felippe ISA et al.. 2026. Vitamin B6 (Pyridoxal 5' Phosphate) antagonises carotid body P2X3 receptors in hypertension.. Cardiovasc Res 122(2):285-296 PMID: 41094718
- 5. Rossignoli G et al.. 2018. Phosphorylation of pyridoxal 5'-phosphate enzymes: an intriguing and neglected topic.. Amino Acids 50(2):205-215 PMID: 29204749
- 6. Cui Z et al.. 2020. Pyridoxal-5'-phosphate-dependent alkyl transfer in nucleoside antibiotic biosynthesis.. Nat Chem Biol 16(8):904-911 PMID: 32483377
- 7. Richard JP et al.. 2009. Pyridoxal 5'-phosphate: electrophilic catalyst extraordinaire.. Curr Opin Chem Biol 13(4):475-83 PMID: 19640775
- 8. Abad AND et al.. 2024. Discovery and Characterization of Pyridoxal 5'-Phosphate-Dependent Cycloleucine Synthases.. J Am Chem Soc 146(21):14672-14684 PMID: 38743881
